滅菌バイアルの世界市場

滅菌バイアルの世界市場は2030年までに100億米ドルに達する見込み

2024年に67億米ドルと推定される滅菌バイアルの世界市場は、2024年から2030年にかけてCAGR 6.8%で成長し、2030年には100億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである無菌空バイアルは、CAGR 5.5%を記録し、分析期間終了までに52億米ドルに達すると予測されます。無菌液体充填バイアルセグメントは、分析期間中CAGR 8.8％で成長すると推定されます。

米国市場は18億米ドルと推定、中国はCAGR10.5％で成長予測

米国の滅菌バイアル市場は2024年に18億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに21億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5％と6.5％と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の滅菌バイアル市場- 主要動向と促進要因のまとめ

なぜ滅菌バイアルが医薬品・バイオテクノロジー進化の中心にあるのか？

滅菌バイアルは、注射薬、ワクチン、生物製剤を保管するために使用されるガラス製またはプラスチック製の密閉容器で、医薬品のサプライチェーンに欠かせないものです。生物製剤、個別化医療、大規模なワクチン接種の増加に伴い、薬剤の安定性、無菌性、およびドラッグデリバリーの制御を確保する上で、その役割は飛躍的に高まっています。一般的な包装容器とは異なり、滅菌バイアルは製品の有効性と患者の安全性を維持するために、厳しい規制、微生物学的、物理化学的基準を満たさなければなりません。これは、モノクローナル抗体、遺伝子治療、RNAベースの薬剤など、汚染や包装による劣化が臨床結果を損なう可能性のある用途では特に重要です。

ガラスバイアル、特にi型ホウケイ酸ガラスは、その耐薬品性と熱安定性により市場を独占しています。しかし、破損、層間剥離、溶出性成分に対する懸念から、ポリマーをベースとした高度な代替品への関心が高まっています。これらのプラスチック製バイアルは、微粒子リスクの低減、軽量設計、高い耐衝撃性などの利点を備えており、特に高スループットの充填仕上げ業務に適しています。無菌バイアル市場は現在、高精度の製造、クリーンルームでの自動化、容器閉鎖の完全性試験といった特徴を持ち、これらはすべて、安全性、一貫性、拡張性に対する製薬業界の妥協のない要求に応えるものです。

材料とプロセスの革新は、無菌バイアル製造をどのように再定義していますか？

バイアル製造における進歩は、純度、寸法安定性、およびスケーラビリティの面で限界を押し広げています。レーザーエッチングとカメラベースの検査システムは現在、100％のトレーサビリティを提供し、統合された充填-仕上げラインは、無菌のアイソレータ制御条件下で洗浄、脱パイロジェン化、充填、およびキャッピングを組み合わせます。これにより、人的介入と汚染リスクを最小限に抑えることができます。新しい洗浄プロトコールと低エンドトキシン処方により、滅菌バイアルは注射剤グレードの厳しい閾値を満たすことができます。

素材の革新も同様に極めて重要です。ガラスが依然として主流である一方で、環状オレフィンポリマー（COP）および環状オレフィンコポリマー（COC）バイアルの台頭は、新たなフロンティアを提示しています。これらのポリマーは優れた透明性、寸法精度、低抽出物を提供し、高感度の生物製剤や高純度の注射剤に適しています。また、ガンマ線滅菌や電子線滅菌にも適合するため、無菌処理の選択肢が広がります。一方、ブローフィルシール（BFS）技術は、単位用量の送達フォーマットで台頭しつつあり、バイアル瓶の無菌形成と密封をワンステップで行うことができます。

滅菌バイアルの需要を形成しているエンドユーズパターンは？

製薬会社やバイオテクノロジー会社は、特に非経口ドラッグデリバリーにおいて、滅菌バイアルの主要な消費者です。慢性疾患の蔓延と生物製剤の急増は、その多くがコールドチェーン保存と無菌包装を必要とするため、高いバリア保護と耐熱性を提供する無菌包装ソリューションの需要を牽引しています。病院や調剤薬局でも、カスタマイズされた混注剤、麻酔薬、診断試薬に滅菌バイアルが使用されています。

パンデミック対策や世界の予防接種プログラムの影響は計り知れません。滅菌バイアルはCOVID-19ワクチンの展開において極めて重要な役割を果たし、スケーラブルでGMPに準拠した製造ラインと堅牢なコールドチェーンパッケージングの必要性にスポットライトを当てました。各国が長期備蓄を構築し、ブースタープログラムが常態化するにつれ、滅菌バイアルの需要は新興経済諸国だけでなく、先進国市場でも拡大し続けています。

動物用医薬品、医薬品製造受託機関（CMO）、研究所も重要なエンドユーザーです。これらのセグメントでは、バッチサイズの柔軟性、高力価の原薬との互換性、既存の無菌充填仕上げラインへの統合のしやすさが重視されています。さらに、自己投与注射剤のような患者中心の投与形態の台頭は、取り扱いを簡素化し暴露リスクを最小限に抑えるプレフィルド無菌バイアル形式への関心を促しています。

滅菌バイアル市場の成長の原動力は？

滅菌バイアル市場の成長は、バイアル材料の進歩、無菌製造技術、医薬品送達モデルのシフトを中心としたいくつかの要因によって牽引されています。材料の面では、ポリマーバイアル技術の革新、特に抽出物を低減し、耐破損性を提供するものが、従来のガラスを超える用途を拡大しています。このような新しいフォーマットは、微量の汚染物質でも有効性を変化させる可能性のある高価値の生物製剤や高感度製剤にとって特に魅力的です。

製造技術の面では、ロボット化されたアイソレーターベースの充填・仕上げシステムの普及により、cGMPおよびAnnex 1ガイドラインに準拠し、最小限の人的介入で無菌バイアル製造が保証されています。これらのシステムは、リアルタイムの環境モニタリング、自動汚染除去、容器閉鎖の完全性検証を提供し、高スループット、低欠陥処理に不可欠です。シリアル化、RFIDタギング、カメラビジョンシステムの統合は、完全なトレーサビリティと偽造防止コンプライアンスをサポートします。

最終用途の拡大も同様に重要な役割を果たします。複雑な生物製剤、個別化治療薬、次世代ワクチンへのシフトは、その多くが温度に敏感であったり、複数回投与レジメンが必要であったりするため、コールドチェーンや長期保管下でも完全性を維持できる包装形態が求められています。CDMOの増加や臨床試験の分散化により、より小さく柔軟なバッチサイズの滅菌バイアルに対する需要も増加しています。無菌性保証や連続化に関する規制の義務化は、精密工学に基づくパッケージング・ソリューションの必要性をさらに高めています。

このような技術主導の業界の動向は、世界の滅菌バイアル市場の持続的かつ高価値な成長を後押ししています。

セグメント

製品（無菌空バイアル、無菌液体充填バイアル、個別無菌コンポーネント）、素材（ガラス素材、プラスチック素材）、容量（2ml未満、2～5ml、5～10ml、10～20ml、20ml以上）、エンドユーザー（臨床ラボエンドユーザー、調合ラボエンドユーザー、バイオ製薬会社エンドユーザー、CMOエンドユーザー、その他エンドユーザー）

調査対象企業の例

• Acme Vial and Glass Company, LLC
• Adelphi Healthcare Packaging
• APG Europe
• Bormioli Pharma S.p.A.
• Corning Incorporated
• Dalton Pharma Services
• DWK Life Sciences GmbH
• Gerresheimer AG
• Kishore Group
• Nipro Corporation
• O.Berk Company
• Pacific Vial Manufacturing, Inc.
• Piramal Glass（Piramal Enterprises Ltd.）
• Qorpak
• SCHOTT AG
• SGD Pharma
• Shandong Pharmaceutical Glass Co., Ltd.
• Stevanato Group S.p.A.
• Thermo Fisher Scientific
• West Pharmaceutical Services, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Sterile Vials Market to Reach US$10.0 Billion by 2030

The global market for Sterile Vials estimated at US$6.7 Billion in the year 2024, is expected to reach US$10.0 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Sterile Empty Vial, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth in the Sterile Liquid Filled Vial segment is estimated at 8.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 10.5% CAGR

The Sterile Vials market in the U.S. is estimated at US$1.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 10.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Sterile Vials Market - Key Trends & Drivers Summarized

Why Are Sterile Vials at the Center of Pharmaceutical & Biotech Evolution?

Sterile vials-hermetically sealed glass or plastic containers used to store injectable drugs, vaccines, and biologics-are indispensable in the pharmaceutical supply chain. Their role in ensuring drug stability, sterility, and controlled dosage delivery has grown exponentially with the rise of biologics, personalized medicine, and large-scale vaccination efforts. Unlike standard packaging containers, sterile vials must meet stringent regulatory, microbiological, and physicochemical standards to maintain product efficacy and patient safety. This is especially critical in applications such as monoclonal antibodies, gene therapies, and RNA-based drugs, where contamination or packaging-induced degradation can compromise clinical outcomes.

Glass vials, particularly Type I borosilicate, dominate the market due to their chemical resistance and thermal stability. However, concerns over breakage, delamination, and leachable elements have accelerated interest in advanced polymer-based alternatives. These plastic vials offer advantages such as reduced particulate risk, lightweight design, and higher impact resistance-especially relevant for high-throughput fill-finish operations. The sterile vial market is now characterized by high-precision manufacturing, cleanroom automation, and container closure integrity testing-all of which serve the pharmaceutical industry's uncompromising demand for safety, consistency, and scalability.

How Are Innovations in Materials and Processes Redefining Sterile Vial Production?

Advancements in vial manufacturing are pushing the envelope in terms of purity, dimensional stability, and scalability. Laser-etching and camera-based inspection systems now provide 100% traceability, while integrated fill-finish lines combine washing, depyrogenation, filling, and capping under sterile, isolator-controlled conditions. This minimizes human intervention and contamination risk. New washing protocols and low-endotoxin formulations ensure that sterile vials meet strict thresholds for injectable-grade use, while advanced lyophilization-compatible designs support freeze-drying processes required for vaccines and biologics.

Material innovation is equally pivotal. While glass remains dominant, the rise of cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) vials presents new frontiers. These polymers offer excellent transparency, dimensional accuracy, and low extractables, making them suitable for sensitive biologics and high-purity injectable formulations. They’re also compatible with gamma and e-beam sterilization methods, broadening options for aseptic processing. Meanwhile, blow-fill-seal (BFS) technology is gaining ground in unit-dose delivery formats, allowing the sterile formation and sealing of vials in a single step-particularly useful in high-volume vaccine and ophthalmic applications.

How Are End-Use Patterns Shaping Demand for Sterile Vials?

Pharmaceutical and biotech companies are the primary consumers of sterile vials, particularly for parenteral drug delivery. The growing prevalence of chronic diseases and the surge in biologics-many of which require cold-chain preservation and aseptic packaging-have driven demand for sterile packaging solutions that offer high barrier protection and thermal resilience. Hospitals and compounding pharmacies also use sterile vials for customized admixtures, anesthetics, and diagnostic reagents.

The impact of pandemic preparedness and global immunization programs cannot be overstated. Sterile vials played a pivotal role in the deployment of COVID-19 vaccines, spotlighting the need for scalable, GMP-compliant manufacturing lines and robust cold-chain packaging. As nations build long-term stockpiles and booster programs become normalized, demand for sterile vials continues to escalate-not just in developed markets but across emerging economies as well.

Veterinary medicine, contract manufacturing organizations (CMOs), and research laboratories represent other critical end users. These segments value flexibility in batch sizes, compatibility with high-potency APIs, and ease of integration into existing sterile fill-finish lines. Additionally, the rise of patient-centric dosing formats-such as self-administered injectables-is spurring interest in pre-filled sterile vial formats that simplify handling and minimize exposure risk.

What’s Driving the Growth in the Sterile Vials Market?

The growth in the sterile vials market is driven by several factors centered around advancements in vial materials, aseptic manufacturing technologies, and shifts in pharmaceutical delivery models. On the materials front, innovations in polymer vial technologies-especially those that reduce extractables and offer break resistance-are expanding usage beyond conventional glass. These new formats are particularly attractive for high-value biologics and sensitive formulations, where even trace contaminants can alter efficacy.

In terms of manufacturing technology, the proliferation of robotic, isolator-based fill-finish systems ensures sterile vial production with minimal human intervention, complying with cGMP and Annex 1 guidelines. These systems offer real-time environmental monitoring, automated decontamination, and container closure integrity verification-making them vital for high-throughput, low-defect processing. Integration of serialization, RFID tagging, and camera vision systems supports full traceability and anti-counterfeiting compliance.

End-use expansion plays an equally crucial role. The shift toward complex biologics, personalized therapies, and next-gen vaccines-many of which are temperature-sensitive or require multi-dose regimens-demands packaging formats that maintain integrity under cold chain and extended storage. The rise of CDMOs and decentralized clinical trials is also increasing demand for sterile vials in smaller, more flexible batch sizes. Regulatory mandates around sterility assurance and serialization further elevate the need for precision-engineered packaging solutions.

Together, these technology-driven and industry-aligned trends are powering sustained and high-value growth in the global sterile vials market.

SCOPE OF STUDY:

The report analyzes the Sterile Vials market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Sterile Empty Vial, Sterile Liquid Filled Vial, Individual Sterilized Components); Material (Glass Material, Plastic Material); Volume (Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume, 10 - 20 ml Volume, Above 20 ml Volume); End-User (Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Acme Vial and Glass Company, LLC
• Adelphi Healthcare Packaging
• APG Europe
• Bormioli Pharma S.p.A.
• Corning Incorporated
• Dalton Pharma Services
• DWK Life Sciences GmbH
• Gerresheimer AG
• Kishore Group
• Nipro Corporation
• O.Berk Company
• Pacific Vial Manufacturing, Inc.
• Piramal Glass (Piramal Enterprises Ltd.)
• Qorpak
• SCHOTT AG
• SGD Pharma
• Shandong Pharmaceutical Glass Co., Ltd.
• Stevanato Group S.p.A.
• Thermo Fisher Scientific
• West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Sterile Vials - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Biologics and Injectable Drug Development Pipelines Propels Demand for Sterile Vial Packaging
  • Expansion of Fill-Finish Contract Manufacturing Services Strengthens Market for Ready-to-Use Vials
  • Strict Regulatory Requirements for Sterility and Contamination Control Drive Quality Upgrades
  • Increased Vaccine and Antibody Therapy Production Expands Addressable Market Volume
  • Adoption of Blow-Fill-Seal and RTU Technologies Accelerates Modernization of Packaging Lines
  • Growth in Personalized Medicine and Small-Batch Drug Production Spurs Flexible Packaging Demand
  • Rising Penetration of Prefilled Systems Enhances Compatibility Requirements for Vial Design
  • Pharma Outsourcing and Global Supply Chain Diversification Generate Consistent Vial Demand
  • Development of High-Value Biologics Strengthens Need for Chemically Inert and Durable Vials
  • Emerging Markets Regulatory Harmonization Opens Opportunities for Global Vial Manufacturers
  • Focus on Cold Chain Integrity Drives Demand for Freeze-Resistant and Thermally Stable Vials
  • Integration of Serialization and Track-and-Trace Capabilities Enhances Packaging Compliance
  • Adoption of Automation in Aseptic Processing Lines Spurs Compatibility with Standardized Vial Formats
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Sterile Vials Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Sterile Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Sterile Empty Vial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Sterile Empty Vial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Sterile Empty Vial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Sterile Liquid Filled Vial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Sterile Liquid Filled Vial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Sterile Liquid Filled Vial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Individual Sterilized Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Individual Sterilized Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Individual Sterilized Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Above 20 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Above 20 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Above 20 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Below 2 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Below 2 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Below 2 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for 2 - 5 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for 2 - 5 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for 2 - 5 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for 5 - 10 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for 5 - 10 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for 5 - 10 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for 10 - 20 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for 10 - 20 ml Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for 10 - 20 ml Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Clinical Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Clinical Labs End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Compounding Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Compounding Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Compounding Labs End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Biopharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Biopharmaceutical Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for CMOs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for CMOs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for CMOs End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Glass Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Glass Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Glass Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Plastic Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Plastic Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Plastic Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• JAPAN
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• CHINA
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 86: China Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• EUROPE
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Sterile Vials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• FRANCE
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 113: France Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• GERMANY
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 149: UK Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Sterile Vials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• INDIA
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 224: India Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Sterile Vials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Sterile Vials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Sterile Vials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Sterile Vials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030
• AFRICA
  • Sterile Vials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Sterile Vials by Product - Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Sterile Vials by Product - Percentage Breakdown of Value Sales for Sterile Empty Vial, Sterile Liquid Filled Vial and Individual Sterilized Components for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Sterile Vials by Volume - Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for Sterile Vials by Volume - Percentage Breakdown of Value Sales for Above 20 ml Volume, Below 2 ml Volume, 2 - 5 ml Volume, 5 - 10 ml Volume and 10 - 20 ml Volume for the Years 2014, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Sterile Vials by End-user - Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Sterile Vials by End-user - Percentage Breakdown of Value Sales for Clinical Labs End-User, Compounding Labs End-User, Biopharmaceutical Companies End-User, CMOs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Sterile Vials by Material - Glass Material and Plastic Material - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Sterile Vials by Material - Glass Material and Plastic Material Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for Sterile Vials by Material - Percentage Breakdown of Value Sales for Glass Material and Plastic Material for the Years 2014, 2025 & 2030

IV. COMPETITION